Hualing Medicine-B (02552.HK) announces profit joy, expecting a profit of approximately 1.184 billion yuan in the mid-term, turning a loss into a profit year-on-year.
Zhijing Finance and Economics APP news, Hualing Pharmaceuticals-B (02552.HK) announced that the group is expected to have a net loss of approximately RMB 142 million for the same period in 2024, and is expected to achieve a surplus of approximately RMB 1.184 billion for the six months ending on June 30, 2025.
Latest